Clinical trials
Uremic Toxins clinical trials
Below are recruiting uremic toxins clinical trials, each written for real people, not researchers. We’re tracking 15 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07333313Recruiting
Study of oral medicine and probiotics for kidney disease in diabetes
This trial tests if an oral medication that absorbs toxins plus probiotics can reduce inflammation and slow kidney damage in people with diabetes-related kidney disease (DKD). It may help those with mild to severe kidney function loss.
Taipei, TaiwanAges 20 years+ - NCT07443280Recruiting
Gut health supplement study for dialysis patients
This trial tests whether a special blend of probiotics and prebiotics (called a synbiotic) can improve gut health and reduce harmful waste products in the blood for people on hemodialysis.
Taichung, Wuqi DistrictAges 18 years+ - NCT05659589Recruiting
Using a kidney toxin level to predict heart effects in AKI
This study looks at whether measuring indoxyl sulfate, a substance that can build up when kidneys are injured, can help predict how blood vessels and the heart are affected during acute kidney injury (AKI). It may help doctors understand who is at higher risk of heart-related problems while AKI is happening.
AmiensAges 18 years+ - NCT04819217Recruiting
Probiotics and a toxin binder to slow chronic kidney disease
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
TaipeiAges 20 years+ - NCT07016841Recruiting
Adding a filter to dialysis to clean your blood better
This study tests whether adding a special filter (hemoperfusion) to your regular hemodialysis can better remove waste products that build up in the blood. It might help people on dialysis feel better and have fewer complications.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07653711Recruiting
Coated aldehyde oxystarch for reducing toxins in kidney failure
This trial tests a new oral medication, coated aldehyde oxystarch, for people on dialysis. It aims to lower certain waste products in the blood that are hard to remove with standard dialysis, which may help reduce long-term complications.
BeijingAges 18 years+ - NCT07461233Recruiting
Gut Health and Synbiotics in Hemodialysis
This study tests whether taking a special mix of friendly bacteria and prebiotics (called synbiotics) can help improve gut health in people on hemodialysis. It may reduce inflammation and other complications related to kidney disease.
Taichung, Wuqi DistrictAges 18 years+ - NCT06794216Recruiting
Comparing dialysis methods to clean blood in kidney failure
This study compares different types of dialysis to see which removes waste products (uremic toxins) best from the blood. If you have been on dialysis for at least 6 months and use the same filter for a year, this trial may help find a better way to clean your blood.
Bologna, Emilia-RomagnaAges 18 years+ - NCT03711617Recruiting
Study of waste products and outcomes in chronic kidney disease
This study looks at “uremic toxins,” which are waste products that build up when kidney function is reduced, and how they relate to health outcomes in people with chronic kidney disease. The results may help doctors better understand what to monitor and target to improve care.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06863194RecruitingPhase 1/Phase 2
Probiotics and kidney disease progression trial
This trial tests whether taking a probiotic supplement can slow down the decline of kidney function in people with moderate chronic kidney disease (CKD stages 3 and 4). If you have stable kidney disease and are not already taking probiotics, joining this study could help researchers find a new way to protect your kidneys.
Al Mansurah, DakahliyaAges 18 years+ - NCT07237451Recruiting
Heart and kidney study of SGLT2 inhibitors
This study looks at whether a type of diabetes medicine called SGLT2 inhibitors (also known as flozins) can help protect the heart and kidneys in people with both heart failure with preserved pumping function and moderate chronic kidney disease, with or without diabetes.
IașiAges 18 years+ - NCT07656168Recruiting
Testing a new blood filter to improve quality of life in kidney failure
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
BeijingAges 18 years+ - NCT06910475Enrolling by invitation
Exercise and biomarker study to reduce toxins in kidney disease
This study tests whether a supervised exercise program can help reduce toxins in the blood for people with chronic kidney disease and metabolic syndrome. Researchers will also look at blood markers to understand how exercise affects the body.
Taguatinga, Federal DistrictAges 18 years+ - NCT05219110Recruiting
More fluids for children sick with toxin E. coli
This study looks at whether giving extra (hyper) fluids early helps children with a high-risk E. coli stomach infection. The goal is to improve outcomes by supporting the kidneys during the illness.
Birmingham, AlabamaAges 9 months–21 years - NCT06065852Recruiting
National registry for rare kidney diseases
This study creates a registry to collect health information from people with rare kidney diseases. It aims to improve understanding and future treatments by tracking patient experiences.
Bristol, South WestAges Any age
Hear when a new Uremic Toxins trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for uremic toxins?
- Yes. Clin2 currently lists 15 recruiting uremic toxins studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a uremic toxins trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a uremic toxins trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.